ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
+12.13%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$360M
AUM Growth
+$360M
(+34%)
Cap. Flow
+$80M
Cap. Flow
% of AUM
22.21%
Top 10 Holdings %
Top 10 Hldgs %
19.65%
Holding
155
New
61
Increased
18
Reduced
21
Closed
31
Top Buys
| 1 |
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
|
$8.32M |
| 2 |
Verrica Pharmaceuticals
VRCA
|
$6.88M |
| 3 |
Aldeyra Therapeutics
ALDX
|
$6.51M |
| 4 |
CareDx
CDNA
|
$5.54M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$5.29M |
Top Sells
| 1 |
IRD
Opus Genetics, Inc. Common Stock
IRD
|
$9.71M |
| 2 |
Genprex
GNPX
|
$5.82M |
| 3 |
AnaptysBio
ANAB
|
$5.62M |
| 4 |
Cogent Biosciences
COGT
|
$4.86M |
| 5 |
Celldex Therapeutics
CLDX
|
$4.01M |
Sector Composition
| 1 | Healthcare | 82.98% |
| 2 | Financials | 2.24% |
| 3 | Consumer Staples | 0.95% |
| 4 | Industrials | 0.89% |
| 5 | Technology | 0.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Curis
CRIS
$20.9M
| $8.74M | 2.43% | 772,009 -50,000 | -6% | -$566K |
|
|
2
Verrica Pharmaceuticals
VRCA
$52.8M
| $8.53M | 2.37% | 562,954 +454,160 | +417% | +$6.88M |
|
|
BIOR
3
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $8.32M | 2.31% | +1,748,252 | New | +$8.32M |
|
|
RCOR
4
DELISTED
Renovacor, Inc.
RCOR
| $7.57M | 2.1% | 753,374 +364,529 | +94% | +$3.66M |
|
5
ESSA Pharma
EPIX
$11.4M
| $6.68M | 1.86% | 230,063 +54,996 | +31% | +$1.6M |
|
|
6
Aldeyra Therapeutics
ALDX
$351M
| $6.51M | 1.81% | +548,225 | New | +$6.51M |
|
7
Verastem
VSTM
$569M
| $6.36M | 1.76% | 2,573,222 -158,752 | -6% | -$392K |
|
8
Protagonist Therapeutics
PTGX
$3.67B
| $6.17M | 1.71% | 238,354 +52,500 | +28% | +$1.36M |
|
|
BLU
9
DELISTED
BELLUS Health Inc.
BLU
| $6.04M | 1.68% | 1,573,389 -109,146 | -6% | -$419K |
|
10
Lantheus
LNTH
$3.73B
| $5.88M | 1.63% | 275,066 +12,601 | +5% | +$269K |
|
11
Syndax Pharmaceuticals
SNDX
$1.41B
| $5.67M | 1.57% | 253,448 -10,148 | -4% | -$227K |
|
|
ISEE
12
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.58M | 1.55% | 902,633 | – | – |
|
|
13
CareDx
CDNA
$727M
| $5.54M | 1.54% | +81,284 | New | +$5.54M |
|
14
Crinetics Pharmaceuticals
CRNX
$2.92B
| $5.53M | 1.54% | 361,930 | – | – |
|
15
Insulet
PODD
$23.9B
| $5.48M | 1.52% | 21,000 +4,800 | +30% | +$1.25M |
|
|
SIEN
16
DELISTED
Sientra, Inc.
SIEN
| $5.39M | 1.5% | 739,045 -13,589 | -2% | -$99.1K |
|
17
Ocular Therapeutix
OCUL
$2.12B
| $5.31M | 1.47% | 326,174 +23,000 | +8% | +$375K |
|
18
Aurinia Pharmaceuticals
AUPH
$1.58B
| $5.31M | 1.47% | 408,908 +114,991 | +39% | +$1.49M |
|
|
NVRO
19
DELISTED
NEVRO CORP.
NVRO
| $5.29M | 1.47% | +37,900 | New | +$5.29M |
|
20
Travere Therapeutics
TVTX
$1.56B
| $5.26M | 1.46% | 210,484 +134,000 | +175% | +$3.35M |
|
21
Myriad Genetics
MYGN
$593M
| $5.23M | 1.45% | 171,785 -46,865 | -21% | -$1.43M |
|
22
Sutro Biopharma
STRO
$72.7M
| $5.16M | 1.43% | 226,719 -50,000 | -18% | -$1.14M |
|
|
MBTCU
23
DELISTED
Nocturne Acquisition Corporation Unit
MBTCU
| $5M | 1.39% | +500,000 | New | +$5M |
|
24
Imunon
IMNN
$15M
| $4.83M | 1.34% | +3,496,154 | New | +$4.83M |
|
25
Rhythm Pharmaceuticals
RYTM
$6.85B
| $4.74M | 1.32% | +223,000 | New | +$4.74M |
|